Resveratrol gel vs. TCA peel for melasma
Part of Skin clinical trials.
This study compares a resveratrol 1% gel to a TCA 20% chemical peel for treating melasma. Each side of your face will get a different treatment so doctors can see which works better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You have melasma on both sides of your face (any pattern).
- Your skin type is Fitzpatrick III, IV, or V (light to dark brown).
- You are not pregnant or breastfeeding.
- You have not taken birth control pills, hormone therapy, or treatments for chronic illness in the past 6 months.
- You do not have scars, keloids, active skin infections, or conditions like Addison's disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two treatments for melasma, a common skin condition causing dark patches on the face. One treatment uses an injection into the affected skin (tranexamic acid), while the other uses a chemical peel (mandelic acid). The study aims to see which works better and is safer for people with darker skin tones.
This trial tests two different triple-combination creams for melasma in women with skin types IV or V. Both creams contain a bleaching agent and a retinoid, but one uses a different steroid. The goal is to see which is safer and works better.
This trial tests two injectable treatments for melasma (dark patches on the face): platelet-rich fibrin, which uses your own blood cells to promote healing, and tranexamic acid, a medication that may reduce pigmentation. The study will compare which works better for women with mild to moderate melasma.
This study tests a new gel (SM-030) for adults with moderate to severe melasma. If you join, you would use the gel on your face for a few months and stop other skin-lightening products, while applying the provided sunscreen every day.
This trial compares two topical creams—tranexamic acid and ethyl ascorbic acid (a form of vitamin C)—to see which works better for melasma, a common skin condition that causes dark patches on the face. The study will help determine which treatment is more effective.
This trial tests if adding MelaB3 serum to a 35% glycolic acid peel works better than the peel alone for treating dark spots caused by melasma, acne scars, or sun damage. It may be a good option if you have mild to moderate dark spots and are willing to avoid sun exposure and other skin-lightening products.
Hear when a new Melasma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.